Efficacy of a Recombinant Genotype VII Vaccine against Challenge with Velogenic Newcastle Disease Virus
Journal of Vaccines and Immunology
Research Article
Research Article
Background: Newcastle disease
virus (NDV) genotype VII has become the dominant genotype in China.
However, NDV genotype II was used to make current commercial NDV
vaccines. The mismatch of genotypes between circulating and vaccine
strains of viruses may compromise the efficacy of vaccines.
#scholarlyfreearticles #scholarlyopenaccess #scholarlyjournals
http://www.peertechz.com/Vaccines-Immunology/pdf/JVI-2-116.pdf
#scholarlyfreearticles #scholarlyopenaccess #scholarlyjournals
http://www.peertechz.com/Vaccines-Immunology/pdf/JVI-2-116.pdf
Comments
Post a Comment